Yadira Torres MAS/LinkedIn
Sep 15, 2026, 11:55
Yadira Torres MAS: Predicting Chronic Immune Thrombocytopenia in Children
Yadira Torres MAS, Executive Director at Children’s Hospital Los Angeles, shared CHLA’s post on LinkedIn:
“A new study led by CHLA may help answer a key question for physicians treating children with immune thrombocytopenia (ITP):
Which patients will recover on their own, and which will develop chronic disease?”
Children’s Hospital Los Angeles (CHLA) shared a post on LinkedIn:
“Which children with immune thrombocytopenia (ITP) will recover on their own and which will develop chronic disease?
A multicenter study led by CHLA’s Dr. Taylor Kim validated a prediction model that could help physicians answer that question when a child is first diagnosed.”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026